HIGHLIGHTS
- who: Huai-liang Wu from the universal gBRCA testing to HR-positive HER2-negative BC and TNBC patients has ICERs of , and , USD/QALY in China have published the Article: All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits, in the Journal: (JOURNAL) of 23/Dec/2022
- what: Given the possible cost-effectiveness of genetic screening and family history-based genetic testing in breast cancer, the focus of the study is to investigate a comprehensive gBRCA testing strategy among patients with breast cancer using a practically simplified screening approach and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.